MjLink Cannabis Business News and Press

Vermont Gov. Phil Scott vetoed legislation last week that would have created a drug use standards advisory board and expanded eligibility for the expungement of non-violent crimes, according to the Associated Press.

The advisory board, which would have been established within the state sentencing commission, would have been responsible for determining “the benchmark personal use dosage and the benchmark personal use supply” for regulated and unregulated drugs, according to the news outlet.

The board’s work was meant to prevent and reduce the criminalization of personal drug use, AP reported, but Scott said the bill to establish the advisory board “places no limits on which drugs can be contemplated for legalization or the amounts” and incudes “absolutely no recognition” of the health and safety impacts of using drugs such as fentanyl and heroin.

The bill also fails to acknowledge the role of law enforcement in stopping drug dealers, Scott said in his May 19 letter to the General Assembly, according to AP.

On the bill would have expanded eligibility for the expungement of non-violent crimes, Scott said in his veto message that he determined the legislation was “inconsistent with the state’s responsibilities to keep the public safe,” according to AP.

New Jersey’s end to cannabis prohibition came with 67.1% of support from voters in the November 2020 election, but now state lawmakers are attempting to scale back that reform.

Earlier this month, Assemblyman Edward Thomson and Assemblywoman Beth Sawyer—both Republicans—introduced legislation, Assembly Bill 3870, that aims to allow employers the ability to prohibit cannabis use by certain employees, even while they’re not working.

Under the proposed legislation, an employer shall prohibit the personal use of cannabis for the following employees:

“This bill amends the Cannabis Regulatory Enforcement Assistance, and Marketplace Modernization (CREAMM) Act to prohibit certain categories of employees from the personal use of recreational cannabis,” according to a bill statement from the sponsors. “Specifically, this bill permits an employer to prohibit any use of cannabis if the person operates heavy machinery or weapons, or whose use of cannabis would put the public at risk. Further, this bill permits employers of law enforcement officers to prohibit use of cannabis.”

All employees prohibited from cannabis use under the legislation would be subject to employer policies as it relates to drug testing.

That legislation is just one of three bills introduced this month that attempts to restrict off-the-job cannabis use by certain workers.

Two New Mexico tribes have signed an agreement with state officials on adult-use cannabis sales, which officially launched in the state April 1.

RELATED: New Mexico’s Ultra Health Reflects on First Days of Adult-Use Sales

The agreement, announced May 19, recognizes the tribes’ authority to collect cannabis sales tax, according to the Associated Press.

New Mexico’s 12% tax on adult-use cannabis will not apply to products sold by the tribes, but the agreement allows the Pojoaque and Picuris pueblos to tax cannabis products similarly to cigarettes and gasoline, the news outlet reported.

RELATED: New Mexico Governor, Pueblos Sign Intergovernmental Agreements on Cannabis

BOSTON, May 23, 2022 /PRNewswire/ -- The Boston Beer Company, Inc. (NYSE:SAM), maker of iconic, high-quality brands such as Samuel Adams, Truly HardSeltzer and Twisted Tea, today announced the launch of TeaPot, a new line ofcannabis-infused iced teas. TeaPot is the company's first infused beverageoffering and will be available in select Canadian provinces beginning in July.

TeaPot blends real tea with specific cannabis strains to enhance specifictimes of the day. The brand's first release is a Good Day Iced Tea, made withreal lemon black tea and infused with Pedro's Sweet Sativa, a unique cultivarwhich is grown in Strathroy, Ontario by licensed producer Entourage HealthCorp. and sold exclusively in Canada under itsretail brand Color Cannabis. Each 12-ounce can of TeaPot contains 5mgof THC and is crafted to minimize any cannabis taste or aroma. TeaPot willintroduce additional varietals in the coming months.

"TeaPot purposefully pairs the right tea with the right pot for theright occasion," said Paul Weaver, Director, Head of Cannabis at TheBoston Beer Company. "Each can is precisely dosed for social gatheringswith friends and family. We think TeaPot is the best-tasting cannabis beverageon the market, and we can't wait for people to try it – we think they'llagree."

Since 2020, Canada's infused beverage market share has increased by nearly850%[1], according to Headset retail data, and is approximatelytwice the size of the U.S. cannabis beverage market.

"Our goal is to be the most innovative consumer-focused beveragecompany on the planet," said Dave Burwick, CEO of The Boston Beer Company."While beer is our middle name, we've also introduced successful hardteas, hard ciders, hard seltzers, and canned cocktails. We're encouraged by thecontinued growth of the cannabis beverage category and we believe it's one ofthe next innovation frontiers. As we await further progress on U.S.regulations, we'll continue to develop an exciting product pipeline in thefederally regulated market of Canada."

TORONTO, May 20, 2022 (GLOBE NEWSWIRE) -- PRESS RELASE -- The Flowr Corporation (TSX.V: FLWR; OTC: FLWPF) herein announces its financial and operational results for the fourth quarter and fiscal year ended Dec. 31, 2021. All financial information in this news release is reported in thousands of Canadian dollars and represents results from continuing operations, unless otherwise indicated.

Tom Flow, Interim Chief Executive Officer of Flowr commented, “2021 was a pivotal year for Flowr as we renewed our focus on maintaining our status as a premium cannabis producer and making the necessary changes to our business operations to reach profitability. The company made significant progress towards this objective, as we continue to take the necessary steps to reduce costs and drive revenues. In Q4 2021, we achieved new records in gross and net revenue at $4.4 million and $3.9 million, respectively, contributed by our previously announced strategy of introducing exciting new genetics and formats, enhancing our retail penetration, and solidifying our world class operations out of the K1 facility.

"Operationally, the K1 facility has been now fully operational since the second half of 2021 and each grow room is being utilized to ensure our fixed costs are being spread out over a higher number of production grams. We have increased our product offerings significantly with the launch and success of Strawnana, Sour Sis, BC Dog Walkers, and in 2022 introduced several new exciting strains including BC Clementine Crush, BC Lemon Ice, BC Spiced Grape and BC Mango Melon OG, with more planned for the rest of 2022. We have also seen significant growth in retail penetration across our core markets with store distribution well over 50%.

"Financially, we have strived to improve our financial position by reducing costs, shedding non-core assets and licenses, significantly reducing overall indebtedness, and raising additional equity capital. The sale of the KRS R&D facility and Holigen as previously announced will further reduce the company’s indebtedness to approximately $10 million, including $5.7 million under the senior credit facility and $5 million of convertible debentures, with further paydowns to the senior credit facility expected in the second quarter. The company has reduced SG&A expenses each quarter since the end of 2020 with Q4 2021 SG&A 16% lower than the same period in 2020.

"As previously announced, we have closed the sale of Holigen for what we believe to be favorable terms for Flowr shareholders. The company undertook a robust sale process and was able to transact upon a deal that gave Flowr a significant amount of cash on closing to solidify its balance sheet and also preserve the upside related to our European operations. We still believe the European market is on the cusp of regulatory change and we believe that Holigen will be able to take advantage of those opportunities with the capital and excellent management team from Akanda.

"Although we did not reach our full objectives for 2021, we are encouraged by the positive steps we have taken to position Flowr in 2022. Through the various changes that have been implemented, we believe Flowr is in a better position to realize its full potential and deliver results. The next few quarters will be an exciting time for Flowr as the Company takes the last steps towards profitability.”

Earlier this month, Glass House Brands announced a definitive agreement to acquire two operational dispensaries and one soon-to-open dispensary from Natural Healing Center.

This acquisition will help to triple the company’s retail footprint in California. With three wholly owned retail stores—operating under the Farmacy brand—Glass House Brands will add these three Natural Healing Center locations, a previously acquired Pottery location and three more Farmacy storefronts set to open later this year.

According to the press release, the two operational NHC dispensaries, in Lemoore and Morro Bay, Calif., “had revenue of $15.3 million from April 2021 through March 2022 with EBITDA margins above 20%.”

The third retail location is in Turlock, south of Modesto.

“This acquisition will advance us further in our goal of becoming one of the largest retailers in the state; provide incremental outlets for flower sales as the SoCal facility comes online; and add further support to our CPG business, including PLUS, our recently acquired and leading cannabis edibles company based in California,” said Kyle Kazan, Glass House Chairman and CEO.

As the state market’s balance between cultivation and retail continues to settle, acquisitions like this are a strategic part of the vertically integrated operator’s growth plans in California. In-state M&A has become one important method for growth, given the relatively slow rollout of additional retail licenses (and additional counties opting in, in the first place, to hosting retail businesses).

Duke Rodriquez laid it out bluntly: New Mexico’s adult-use cannabis retail program underperformed in April, the first month for the new market.

Rodriguez, the president and CEO of Ultra Health, a vertically integrated operator with 38 dispensaries serving both patients and adult-use customers in the state, said the nearly $39.5 million in combined adult-use and medical sales recorded by licensed dispensaries were about 25% short of his expectations.

“I think we’re about $10 million light,” he said. “That’s the concern.”

Specifically, New Mexico retailers recorded more than $22.1 million in adult-use sales and $17.3 million in medical sales in April, according to the state’s Cannabis Control Division.

“The first signs are not all that impressive,” Rodriguez said. “Again, we should have done $20 million falling off a log with medical, and so, literally, we dropped off of medical and made a little bit more room for adult, but the aggregate was not that impressive.”

Rodriguez’s $50-million benchmark for April was two-fold.

Trulieve, a multistate cannabis company, celebrated the grand opening of its third and fourth medical cannabis dispensaries in West Virginia this weekend. 

"Located at 4701 MacCorkle Ave. SW in South Charleston and 152 Park Shopping Center in Parkersburg, both dispensaries opened at 10 a.m. on Saturday, May 21," according to a press release.

The grand openings included food, music, giveaways, and product deals and specials. The company also launched two new cultivars Chocolope Newberry Live Budder and Pineapple Upside Down Cake Flower, which are only available at the two new dispensaries, according to the release. 

"We are thrilled to expand medical cannabis in West Virginia and deliver on our commitment to serving patient communities with high quality and reliable medical cannabis products," Trulieve CEO Kim Rivers said. "We look forward to welcoming patients across West Virginia and strengthening community connections in this developing market."

The company also plans on adding five more locations to its West Virginia footprint in the future. According to the release, it has its sights set on Belle, Huntington, Hurricane, Milton and Morgantown-Granville.

CRANFORD, New Jersey, May 23, 2022 - PRESS RELEASE - Bennabis Health, a company filling holes in the health insurance industry for medical cannabis patients, is thrilled to announce a contractual partnership with The Botanist dispensaries of Southern New Jersey as the next step of advancing its mission to increase medical cannabis affordability and growing its membership program.

Bennabis Health is the first company to offer a membership program for patients eligible for a medical cannabis card. The company's leadership is a council of highly experienced NJ-based health insurance and cannabis industry operations professionals whose focus is on easing the financial burdens of those who can benefit from medical cannabis.

Patients who have or get a medical cannabis card will now be able to find Bennabis Health membership program benefits available at The Botanist locations in New Jersey, including Atlantic City, Egg Harbor Township and Williamstown.

"The continuing growth of our membership plan in partnership with The Botanist is the next step in our national rollout plan to increase patient access across the country," said Bennabis Health president Don Parisi. "Expanding access and affordability across our home state has been a top priority."

The Botanist dispensaries are developed by Acreage Holdings, Inc and provide a carefully curated retail and product experience for consumers. They offer high-quality products and pay meticulous attention to every detail, from seed to sale. The Botanist's product line in New Jersey includes a wide variety of whole flower strains, pre-rolls and vape cartridges available in the brand's retail locations and other dispensaries. For more information on The Botanist, visit ShopBotanist.com.

"The Botanist has proudly served New Jersey medical patients for almost five years and is thrilled to partner with Bennabis Health to continue providing access and affordable health coverage to patients across the state," said Brian Sickora, Acreage General manager for the state of New Jersey.

FORT LAUDERDALE, Florida, May 23, 2022, - PRESS RELEASE - Flora Growth Corp., an all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, announced today that it has entered into an agreement with cell biologist Annabelle Manalo-Morgan, Ph.D., to acquire her brand Masaya, together with its patent-pending CBD formulations. Created by Annabelle and backed by her research, Masaya’s formulations of pure, potent CBD oil are 100% THC-free. Flora intends to distribute the brand and its formulations worldwide.

Masaya will become an owned Flora brand sold in the US and will be the first offering from Flora Life Sciences. In addition, it is expected that the original patent-pending formulation, Masaya Pure, will be used in Flora’s current clinical trials with the University of Manchester in the UK. The formulation is also in the process of being registered with the Colombian regulatory agency, INVIMA, as one of the first distribution steps beyond the US.

“We are excited to announce the acquisition of Masaya. The brand’s formulation was developed by Annabelle for her son and has since been used by thousands of consumers. Amplifying Annabelle and her son’s beautiful story and improving the well-being of people around the world is our aim,” Flora’s chairman and CEO Luis Merchan said. “This acquisition allows us to deliver on our promise to invest in safe, thorough, cutting-edge scientific research that can bring meaningful change via an efficacious and accessible product offering for people worldwide.”

As a member of Flora’s Board of Directors and as the company’s Scientific Advisor, Annabelle is responsible for leading Flora’s global research initiatives, including Flora’s ongoing clinical trial on the use of cannabinoids with patients who have fibromyalgia in partnership with the University of Manchester in the UK. Those clinical trials are expected to expand into research on the use of cannabinoids for other medical indications in the UK, at Flora’s research facilities in Colombia, and in the US. It is anticipated that proceeds from the sale of Masaya products will contribute to the funding of this vital research.

CHICAGO, May 23, 2022 – PRESS RELEASE – Verano Holdings Corp., through its subsidiary, Verano Holdings LLC, yesterday notified the U.S. District Court for the District of Colorado of its complete victory in arbitration regarding various frivolous RICO (Racketeer Influenced and Corrupt Organizations Act) claims brought by Nicholas Nielsen. The arbitrator dismissed all of Nielsen’s claims with prejudice and awarded Verano nearly $100,000 in attorney’s fees in the arbitration, further underscoring the groundless nature of the lawsuit.

In his claims, originally brought in Federal Court but ultimately adjudicated on the merits in arbitration, Nielsen failed to disclose that he had pled guilty to a four-count felony indictment in the state of Arkansas for the blatantly illegal cannabis cultivation and production operation he ran out of his home. Nielsen’s claims were a meritless effort to shift blame to Verano and more than 50 other defendants for his conviction, which was based on illegal activity in which he engaged on his own volition and without the knowledge or involvement of Verano or others.

“The allegations in the complaint are completely and totally false and absurd,” said George Archos, Verano founder and CEO. “The plaintiff and his lawyer have turned an employment dispute between a former employee and his employer into a sensationalized and imagined series of events aimed at a company like Verano with a proven track record of compliant operations. Verano and its affiliates are proud of their strict compliance with, and adherence to, state laws and regulations, and any insinuation to the contrary is completely fictional.”

With operations in 13 states, all with highly regulated state-legalized cannabis programs, Verano is a leading, vertically integrated multistate cannabis operator in the United States. This complete victory for Verano validates its vigorous efforts to defend itself from these false, baseless and defamatory allegations that struck at one of Verano’s core foundational principles—strict compliance with applicable law.

SANTA BARBARA, Calif., May 20, 2022 /PRNewswire/ -- PRESS RELEASE-- HERBL, a California-based cannabis supply chain company, today announced exclusive distribution partnerships with Ball Family Farms, a Black-owned cannabis brand, and 40 Tons, a Black female-owned social impact cannabis brand. HERBL begins distribution of both brands' range of cannabis products in California this month, an opportune time to drive visibility to Cannabis Freedom Day, or 520, and Brand efforts towards social equity and justice in the cannabis industry.

Ball Family Farms is a social equity commercial operator that cultivates hand-crafted flower. Founded by Chris Ball, a former legacy operator and professional athlete, Ball Family Farms uses proprietary, in-house genetics as well as living soil and sustainable cultivation systems. Prioritizing equal pay, diversity and women's empowerment in the workplace, Ball Family Farms fosters a positive company culture and a passion for exceptional cannabis products. Popular strains include Daniel Larusso, Dragonfly Jones, Nino Brown and more.

"Ball Family Farms operates by our motto, 'cultivating the culture from the ground up,' in each new venture we undertake," said Chris Ball, founder of Ball Family Farms. "Our partnership with HERBL is no exception. Between their widespread reach in California and commitment to cannabis culture in our state, HERBL is the perfect partner as our growing brand looks to the future."

40 Tons was founded by Loriel Alegrete, Anthony Alegrete and Corvain Cooper, who experienced the impact of cannabis prohibition firsthand when Anthony and Cooper were incarcerated on cannabis charges. Upon Anthony's release, he and Loriel began to advocate for Cooper to be released from his life sentence for non-violent cannabis distribution charges. Cooper ultimately received a rare clemency in 2021. 40 Tons began with the mission to not only provide high-quality cannabis experiences but also to increase the representation of BIPOC communities in cannabis and advocate for those experiencing incarceration. The brand built advocacy directly into its business model by investing profits from each purchase into social equity efforts. 40 Tons' product line, which features full-size 1g pre-rolls and 1/8th flower packs in a variety of strains, will be available throughout California on May 30.

"With the support of HERBL, 40 Tons will be able to impact significantly more lives," said Loriel Alegrete, CEO and co-founder of 40 Tons Brand. "Sharing our brand and story with new audiences not only introduces consumers to our quality products but also enables our team to fund even more restorative justice initiatives. HERBL's hands-on approach and organic relationship with our team place 40 Tons in a prime position to succeed."

It was important to 40 Tons to launch close to, and to give visibility to, Cannabis Freedom Day. Cannabis Freedom Day is an industry holiday that brings awareness to the disproportional social, racial and economic injustices that BIPOC communities have faced due to cannabis prohibition. The 40 Tons team is driving visibility on this day through their social platforms.

Siskiyou County, Calif. Sheriff Jeremiah LaRue says illicit cannabis cultivation has created an environmental crisis and an increase in violent crime in his jurisdiction, and he wants Gov. Gavin Newsome to step in to provide assistance.

LaRue is asking Newsom to declare a State of Emergency for the county to secure more law enforcement funding and tougher laws for illegal grows, according to a local Action News Now report.

RELATED: San Bernardino County Backs California Legislation to Combat Illicit Cannabis Grows

LaRue estimates that there are roughly 5,000 unlicensed outdoor cultivation sites on federal and private land in Siskiyou County, the news outlet reported, and says the illicit grows are linked to increased violent crime in the community.

LaRue also says that trash, human waste, fertilizers, pesticides and other chemicals tied to the illegal  cultivation sites have created an environmental crisis in Siskiyou County, according to Action News Now.

A bill to legalize a commercial adult-use cannabis industry in Delaware gained majority support among House lawmakers May 19 but came one vote shy of the supermajority it needed to pass amidst a key supporter’s absence.

Since House Bill 372 would create a new tax—a 15% cannabis excise tax that would be levied on retail sales—the legislation needs three-fifths majority, or 25 votes, to pass the Democrat-controlled Delaware House.

But with Majority Whip John “Larry” Mitchell, a retired police officer who supports the bill, out sick from the floor vote on Thursday, the legislation came one vote shy of the 25 it needed to pass, The Associated Press reported.

Ultimately, the effort was defeated in a 23-15 vote—with two representatives absent and one choosing not to vote—because the bill’s sponsor, Rep. Ed Osienski changed his vote to “no” at the last minute, a procedural move that allows him, a member who voted with the prevailing side, to bring the legislation back to the floor for reconsideration when the chamber reconvenes from a two-week recess next month, according to the news outlet.

“Coming into today, I thought it was going to be a good day,” Osienski told the Delaware News Journal. “This whole thing has been up and down, up and down. This was a down.”

While Osienski, who thought he had the necessary votes for the Delaware Marijuana Control Act to pass, hit a bump on Thursday, he succeeded earlier this month in getting companion legislation, H.B. 371, passed out of the General Assembly and to Gov. John Carney’s desk.

U.S. Virgin Islands officials are working toward approving medical cannabis regulations, although it remains unclear when rules will be finalized for the program, which was legalized in 2019.

The USVI Cannabis Advisory Board (VICAB), the oversight board for the medical cannabis industry, held a Town Hall meeting Feb. 28 and published proposed rules online, according to The Virgin Islands Daily News.

The draft rules are still under review by the V.I. Justice Department, the news outlet reported. Once the department completes its review, the VICAB will meet again to review and approve the proposed regulations. That will trigger a new 30-day public comment period, according to The Virgin Islands Daily News, after which the board will review the comments and meet one more time to approval the final rules.

V.I. Office of Cannabis Regulation Executive Director Hannah Carty told the news outlet that it will take roughly 55 days to roll out the medical cannabis business application process once the final rules are adopted.

“It takes time and is a very detailed process,” Carty said. “We only get one chance to get the rollout correct, and we need to be as thorough as possible. This has been a lengthy process, but we will all be more appreciative of a product that is cohesive and well-thought out.”

Louisiana lawmakers have advanced a proposal to protect employees who use medical cannabis from negative consequences at work.

The House Committee on Labor and Industrial Relations voted May 19 to unanimously approve Rep. Mandie Landry’s, D-New Orleans, House Bill 988, which would shield employees from being fired, as well as protect job candidates from being discriminated against, if they are a registered medical cannabis patient, according to the Louisiana Illuminator.

The legislation would not apply to law enforcement, firefighters or other public safety officials, the news outlet reported.

“There are a lot of people who don’t want to take opioids for their long-term PTSD and pain management because of the high possibility of addiction to opioids,” Landry told the Louisiana Illuminator. “This has proved to be a better option than them.”

There are currently more than 43,000 registered medical cannabis patients in Louisiana, according to the news outlet, and the state’s first dispensaries opened in 2019.

San Diego has 26 cannabis dispensaries operating within the city, as of May 2022, with another 10 licenses awaiting their applicants. To provide a measure of equity to the burgeoning industry, city officials will hold nine “listening sessions” with community members.

“Your voice will help us develop a blueprint for a future equity program that provides fair pathways for all to enter the legal cannabis industry throughout the city,” according to the announcement.

With a thriving illicit market in southern California, major cities like San Diego and Los Angeles have pushed social equity proposals to the forefront—with mixed results. The San Diego initiative aims to place the perspectives of its residents right in the middle of any future policy.

The sessions run May 23 – June 16 at locations throughout the city. "The areas selected have been ones that have historically seen disinvestment," Lara Gates, the Cannabis Business Deputy Director for San Diego, told the local CBS affiliate. 

Each week, we seem to come tantalizingly close to adding another state to the map of legal U.S. adult-use cannabis markets. 

This week is no different—but it feels different.

Rhode Island legislators are rounding the bend on a bill to legalize adult-use cannabis production and sales, which, if they can cross the finish line next week, would give us the 19th state to pass such a law. If that happens, expect sales to begin at the end of this year.

And keep an eye on Delaware, while you’re at it: The Delaware House missed a chance to advance a cannabis legalization bill just by sheer bad timing, but there’s an opportunity to recast the vote next month.

Rhode Island and Delaware both fall on the low end of state populations (No. 43 and 44, respectively), but the passage of those bills would add some serious heft to the Mid-Atlantic and New England cannabis market in the aggregate.

We’ve rounded up some of the key cannabis headlines from the week right here.

New York Cannabis Control Board (CCB) members approved their third batch of conditional adult-use cannabis cultivation licenses for the 2022 growing season during their regular meeting May 19.

Giving the thumbs up to 58 existing hemp farmers on Thursday, CCB members have now OK’d 146 licensees total: The five board members originally approved licenses for 52 hemp farmers during their April 14 meeting, and another 36 during their May 5 meeting.

The board resolutions for the issuance of those conditional licenses come after Gov. Kathy Hochul signed legislation Feb. 22 to allow hemp businesses to grow cannabis to help jumpstart the adult-use market and ensure there’s adequate supply when commercial sales possibly launch later this year.

Office of Cannabis Management (OCM) Director Chris Alexander, who has spearheaded the license application vetting process, recommended the approval of the 146 licenses that CCB members have voted on so far.

“We’ve received more than 200 applications from New York’s hemp farmers and are excited to continue to advance the Seeding Opportunity Initiative,” he said during the May 19 meeting.

“We’re moving quickly knowing that the growing season is short and wanting for our farmers to take full advantage of that season,” Alexander said. “With the applications hopefully approved today, we’ll have 146 small farmers operating throughout the state of New York as conditional cultivators in the Seeding Opportunity Initiative.”

Three armed male suspects robbed a cannabis dispensary on East Colorado Boulevard in Pasadena, Calif., Wednesday afternoon. 

According to CBS News, the Los Angeles Sheriff’s Department responded to the robbery after receiving reports of shots fired. When deputies arrived, the suspects reportedly fired several shots and fled the scene in a grey Dodge Charger, which led to a short pursuit on the freeway, but the suspects were able to get away. No injuries were reported.

Authorities said the suspects got away with cannabis and a purse that contained an unknown amount of cash, CBS News reported. 

Deputies later located a car matching the suspects’ Charger off Atlantic Boulevard in Alhambra, Calif.—about ten minutes away from the dispensary location—but no further information has been reported, according to CBS News.